Skip to main content

Table 3 Echocardiographic left ventricular functional data

From: Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus

 

SHR (n = 16)

SHR-APO (n = 16)

SHR-DM (n = 13)

SHR-DM-APO (n = 14)

MFS (%)

25.9 ± 3.02

25.1 ± 3.53

25.8 ± 2.36

26.3 ± 3.05

TDI S’ (average, cm/s)

3.25 (2.63–3.38)

2.75 (2.50–3.19)

3.00 (2.75–3.00)

2.75 (2.50–3.00)

Tei index

0.61 ± 0.09

0.61 ± 0.12

0.60 ± 0.09

0.61 ± 0.12

E/A

1.72 ± 0.56

1.64 ± 0.58

1.38 ± 0.45

1.70 ± 0.38

IVRT (ms)

31.9 ± 3.12

32.9 ± 5.05

37.2 ± 4.00*

38.9 ± 5.57#

E/E’

23.3 ± 4.65

24.3 ± 5.03

23.6 ± 4.19

24.1 ± 5.99

  1. Data are expressed as mean ± standard deviation or median and 25th and 75th percentiles
  2. SHR spontaneously hypertensive rats; SHR-APO SHR treated with apocynin; SHR-DM diabetic SHR; SHR-DM-APO diabetic SHR treated with apocynin; MFS midwall fractional shortening; TDI S’ tissue Doppler imaging (TDI) of mitral annulus systolic velocity; E/A ratio between early (E)-to-late (A) diastolic mitral inflow; IVRT isovolumic relaxation time; E’ TDI of early mitral annulus diastolic velocity
  3. Two-factor ANOVA; * p < 0.05 vs SHR; # p < 0.05 vs SHR-APO